US Stock Market Move | Biopharmaceutical company Aptorum Group Limited Class A (APM.US) rises over 248% in pre-market trading.

On Tuesday, shares of Aptorum Group Limited Class A (APM.US) surged over 248% in pre-market trading, reaching $4.72. Aptorum Group Limited Class A is a preclinical stage pharmaceutical company that is actively seeking therapeutic projects in the fields of neurology, infectious diseases, gastroenterology, oncology, and other areas, with exclusive licensing of 11 patented technologies in the related areas. The company's projects such as ALS-4, SACT-1, and RPIDD are promising, but market challenges still exist.